Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CME (CME)

CME Group reports record Q3 revenue of $1.7 billion; diluted EPS rises to $2.89

Positive Impact 3 of 5 earnings

CME Group reported third-quarter 2026 results on October 21, 2026, with revenue of $1.7 billion, up from $1.5 billion a year earlier, and diluted earnings per share of $2.89, up from $2.49. Adjusted diluted EPS was $3.02 versus $2.68 a year earlier, and the company returned nearly $1 billion to shareholders during the quarter.

Key points

  • Q3 2026 total revenues of $1,737.3 million versus $1,537.6 million in Q3 2025
  • Diluted EPS of $2.89 versus $2.49; adjusted diluted EPS of $3.02 versus $2.68
  • Average daily volume of 29.4 million contracts, a third-quarter record
  • Returned nearly $1 billion to shareholders: $465 million in dividends and $524 million in share repurchases

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECOct 21, 2026, 7:13 AM ET
Accession number0001156375-26-000065

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.